List of Neurontin drug patents

Neurontin is owned by Viatris.

Neurontin contains Gabapentin.

Neurontin has a total of 2 drug patents out of which 2 drug patents have expired.

Expired drug patents of Neurontin are:

  • US7256216
  • US7256216*PED

Neurontin was authorised for market use on 02 March, 2000.

Neurontin is available in solution;oral dosage forms.

The generics of Neurontin are possible to be released after 28 November, 2022.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7256216 VIATRIS Liquid pharmaceutical compositions
May, 2022

(1 year, 4 days ago)

US7256216

(Pediatric)

VIATRIS Liquid pharmaceutical compositions
Nov, 2022

(6 months ago)

Do you want to check out NEURONTIN patents from before 2022?

Drugs and Companies using GABAPENTIN ingredient

Market Authorisation Date: 02 March, 2000

Treatment: NA

Dosage: SOLUTION;ORAL

How can I launch a generic of NEURONTIN before it's patent expiration?
More Information on Dosage

NEURONTIN family patents

4

United States

1

Panama

IB

1

IB

1

Spain

1

Hong Kong

1

Austria

1

Dominican Republic

1

Malaysia

1

Iceland

1

Denmark

AP

1

AP

1

Czech Republic

1

Poland

1

Germany

1

China

YU

1

Yugoslavia

1

Brazil

1

Canada

1

Estonia

1

Morocco

1

Ukraine

1

Argentina

EA

1

EA

1

Norway

1

Japan

OA

1

OA

1

New Zealand

1

Croatia

1

Korea, Republic of

1

Guatemala

1

Peru

1

Portugal

1

El Salvador

1

Georgia

1

Mexico

1

Australia

1

Costa Rica

1

Ecuador

1

Bulgaria

1

South Africa

1

Slovakia

1

Egypt

1

Tunisia

1

Slovenia

1

Hungary

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in